Skip to main content
. 2010 Sep 29;48(12):4417–4425. doi: 10.1128/JCM.02458-09

TABLE 2.

Updated CLSI criteria for interpretation of susceptibility testing of carbapenemsa

Agent MIC breakpoint (μg/ml)
Disk diffusion breakpoint (mm)
S I R S I R
IPM ≤1 2 ≥4 ≥23 20-22 ≤19
MEM ≤1 2 ≥4 ≥23 20-22 ≤19
ERT ≤0.25 0.5 ≥1 ≥23 20-22 ≤19
DOR ≤1 2 ≥4 ≥23 20-22 ≤19
a

See reference 7. S, susceptible; I, intermediate; R, resistant.